Medizinische Universität Graz - Research portal
Zurl Hanna |
** = Publications listed in SCI/SSCI/Pubmed
2025
Full paper/article (Journal)
** Dagnino, F; Labban, M; Berk, B; Qian, Z; Stelzl, D; Zurl, H; Korn, S; Lughezzani, G; Buffi, NM; Cole, AP; Kibel, AS; Trinh, QD; Niknejad, KG
Trends and Safety of Same-Day Discharge for Robot-Assisted Laparoscopic Prostatectomy: a Comparison between the Pre-Pandemic and Pandemic Periods from the National Cancer Database.
Urology. 2024;
Doi: 10.1016/j.urology.2024.10.049
Web of Science
PubMed
FullText
FullText_MUG
** Dagnino, F; Qian, Z; Labban, M; Stelzl, D; Zurl, H; Korn, S; Beatrici, E; Lughezzani, G; Buffi, NM; Lipsitz, SR; Kibel, AS; Osman, N; Trinh, QD; Cole, AP
Investigating the pattern of prostate specific antigen screening among E-cigarette smokers within the behavioral risk factor surveillance system.
Urol Oncol. 2024;
Doi: 10.1016/j.urolonc.2024.09.036
Web of Science
PubMed
FullText
FullText_MUG
** Korn, SM; Qian, Z; Zurl, H; Piccolini, A; Pohl, KK; Lipsitz, S; Zhang, J; Kibel, AS; Moore, CM; Rana, HQ; Kilbridge, KL; Shariat, SF; Loeb, S; Trinh, QD; Cole, AP
Disparities in Tissue-based Biomarker Testing Among U.S. Medicare Beneficiaries with Prostate Cancer.
JNCI Cancer Spectr. 2025;
Doi: 10.1093/jncics/pkaf051
PubMed
FullText
FullText_MUG
** Zurl, H; Dagnino, F; Shabo, M; Mahmood, R; Allar, BG; Gershman, B; Weissman, L; Ortega, G; Hastings, S; Rayala, HJ
Prostate Cancer Screening Among Traditionally Underserved Populations at a Large Public Safety-Net Institution
J GEN INTERN MED. 2025;
Doi: 10.1007/s11606-025-09502-w
Web of Science
PubMed
FullText
FullText_MUG
** Zurl, H; Qian, Z; Stelzl, DR; Dagnino, F; Korn, SM; Labban, M; Lipsitz, SR; Leitsmann, M; Ahyai, S; Ellimoottil, C; Loeb, S; Iyer, HS; Trinh, QD; Cole, AP
Carbon Emissions From Patient Travel for Health Care.
JAMA Netw Open. 2025; 8(3):e252513
Doi: 10.1001/jamanetworkopen.2025.2513
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Review
** Cole, AP; Qian, Z; Gupta, N; Leapman, M; Zurl, H; Trinh, QD; Sherman, JD; Loeb, S; Iyer, HS
Urology on a changing planet: links between climate change and urological disease.
Nat Rev Urol. 2025;
Doi: 10.1038/s41585-024-00979-4
Web of Science
PubMed
FullText
FullText_MUG
2024
Full paper/article (Journal)
** Qian, Z; Xiao, B; Dagnino, F; Feldman, J; Song, J; Zurl, H; Stelzl, D; Korn, S; Reis, L; Moore, CM; Trinh, QD; Cole, AP
Real-World Safety of Prostate Cancer Focal Therapy: MAUDE Database Analysis.
J Endourol. 2024;
Doi: 10.1089/end.2024.0573
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Scheipner, L; Zurl, H; Altziebler, JV; Pichler, GP; Schöpfer-Schwab, S; Jasarevic, S; Gaisl, M; Pohl, KC; Pemberger, K; Andlar, S; Hutterer, GC; Bele, U; Leitsmann, C; Leitsmann, M; Augustin, H; Zigeuner, R; Ahyai, S; Mischinger, J
Charlson-Deyo Comorbidity Index as a novel predictor for recurrence in nonmuscle invasive bladder cancer
EUR UROL. 2024; 85: S2123-S2124.
[Oral Communication]
Web of Science
2023
Full paper/article (Journal)
** Scheipner, L; Zurl, H; Altziebler, JV; Pichler, GP; Schöpfer-Schwab, S; Jasarevic, S; Gaisl, M; Pohl, KC; Pemberger, K; Andlar, S; Hutterer, GC; Bele, U; Leitsmann, C; Leitsmann, M; Augustin, H; Zigeuner, R; Ahyai, S; Mischinger, J
Charlson-Deyo Comorbidity Index as a Novel Predictor for Recurrence in Non-Muscle-Invasive Bladder Cancer.
Cancers (Basel). 2023; 15(24):
Doi: 10.3390/cancers15245770
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Zurl, H; Embacher, S; Schollnast, H; Talakic, E; Geyer, M; Schopfer-Schwab, S; Rosenlechner, D; Scheipner, L; Jasarevic, S; Seidl, M; Altziebler, J; Mannweiler, S; Riedl, J; Schwantzer, G; Ahyai, S; Mischinger, J
Prostate tumor volume is a significant predictor to identify patients with no need for concomitant systematic biopsy in men undergoing transrectal ultrasound- MRI fusion guided biopsy of the prostate
EUR UROL. Abstracts. 2023; 83(S1):S442-S442.-38th Annual EAU Congress; MAR 10-13, 2023; Milan, ITALY.
[Poster]
Web of Science
2022
Full paper/article (Journal)
** Mischinger, J; Schöllnast, H; Zurl, H; Geyer, M; Fischereder, K; Adelsmayr, G; Igrec, J; Fritz, G; Merdzo-Hörmann, M; Elstner, J; Schmid, J; Triebl, A; Trimmel, V; Reiter, C; Steiner, J; Rosenlechner, D; Seles, M; Pichler, GP; Pichler, M; Riedl, J; Schöpfer-Schwab, S; Strobl, J; Hutterer, GC; Zigeuner, R; Pummer, K; Augustin, H; Ahyai, S; Mannweiler, S; Fuchsjäger, M; Talakic, E
Combining targeted and systematic prostate biopsy improves prostate cancer detection and correlation with the whole mount histopathology in biopsy naïve and previous negative biopsy patients.
Front Surg. 2022; 9: 1013389
Doi: 10.3389/fsurg.2022.1013389
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2017
Full paper/article (Journal)
** Stelzl, E; Appel, HM; Mehta, R; Marins, EG; Berg, J; Paar, C; Zurl, H; Santner, BI; Kessler, HH
Evaluation of the new cobas® HCV genotyping test based on real-time PCRs of three different HCV genome regions.
Clin Chem Lab Med. 2017; 55(4):517-521
Doi: 10.1515/cclm-2016-0620
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG